Advanced Instruments has established a distribution agreement for GloCyte
Client: Advanced Instruments (Windjammer Capital Investors)
Client Location: U.S.
Target: GloCyte (a division of Advanced Instruments)
Target Location: U.S.
Buyer Location: Japan
Target Description: GloCyte is an automated cell counter using cerebrospinal fluid samples to provide accurate cell counts at clinically relevant low levels.
Meet our Senior Team
View More Transactions
Lincoln International advised AL-KO, a portfolio company of Primepulse, on the sale of AL-KO Air Technology to Trane Technologies
Lincoln International advised ATL Partners on the acquisition of Aero Accessories
Lincoln International advised SiXworks on receiving significant investment from Chiltern Capital
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Müller Transporte on its agreement to sell 70% to Cube Infrastructure Managers
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.